Atwood et al. BMC Genomics 2011, 12:14 http://www.biomedcentral.com/1471-2164/12/14 Received: 16 April 2010 Accepted: 7 January 2011 Published: 7 January 2011 References 1. Levoye A, Dam J, Ayoub MA, Guillaume JL, Jockers R: Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep 2006, 7(11):1094-1098. 2. Jacoby E, Bouhelal R, Gerspacher M, Seuwen K: The 7 TM G-protein- coupled receptor target family. ChemMedChem 2006, 1(8):761-782. 3. Davies MN, Secker A, Freitas AA, Mendao M, Timmis J, Flower DR: On the hierarchical classification of G protein-coupled receptors. Bioinformatics 2007, 23(23):3113-3118. 4. Davies MN, Gloriam DE, Secker A, Freitas AA, Mendao M, Timmis J, Flower DR: Proteomic applications of automated GPCR classification. Proteomics 2007, 7(16):2800-2814. 5. Davies MN, Secker A, Halling-Brown M, Moss DS, Freitas AA, Timmis J, Clark E, Flower DR: GPCRTree: online hierarchical classification of GPCR function. BMC Res Notes 2008, 1:67. 6. Kolakowski LF Jr: GCRDb: a G-protein-coupled receptor database. Receptors Channels 1994, 2(1):1-7. 7. Horn F, Bettler E, Oliveira L, Campagne F, Cohen FE, Vriend G: GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res 2003, 31(1):294-297. 8. Bockaert J, Marin P, Dumuis A, Fagni L: The ‘magic tail’ of G protein- coupled receptors: an anchorage for functional protein networks. FEBS Lett 2003, 546(1):65-72. 9. Brink CB, Harvey BH, Bodenstein J, Venter DP, Oliver DW: Recent advances in drug action and therapeutics: relevance of novel concepts in G- protein-coupled receptor and signal transduction pharmacology. Br J Clin Pharmacol 2004, 57(4):373-387. 10. Pluder F, Morl K, Beck-Sickinger AG: Proteome analysis to study signal transduction of G protein-coupled receptors. Pharmacol Ther 2006, 112(1):1-11. 11. Eglen RM: Emerging concepts in GPCR function–the influence of cell phenotype on GPCR pharmacology. Proc West Pharmacol Soc 2005, 48:31-34. 12. Hall RA, Lefkowitz RJ: Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ Res 2002, 91(8):672-680. 13. Tobin AB, Butcher AJ, Kong KC: Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 2008, 29(8):413-420. 14. Hollinger S, Hepler JR: Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 2002, 54(3):527-559. 15. Hague C, Bernstein LS, Ramineni S, Chen Z, Minneman KP, Hepler JR: Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J Biol Chem 2005, 280(29):27289-27295. 16. Wise A, Gearing K, Rees S: Target validation of G-protein coupled receptors. Drug Discov Today 2002, 7(4):235-246. 17. Thomas P, Smart TG: HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods 2005, 51(3):187-200. 18. Mackie K, Lai Y, Westenbroek R, Mitchell R: Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 1995, 15(10):6552-6561. 19. Mackie K, Devane WA, Hille B: Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 1993, 44(3):498-503. 20. Choi Y, Lim SY, Jeong HS, Koo KA, Sung SH, Kim YC: Oligonucleotide microarray analysis of apoptosis induced by 15-methoxypinusolidic acid in microglial BV2 cells. Br J Pharmacol 2009, 157(6):1053-1064. 21. Loane DJ, Stoica BA, Pajoohesh-Ganji A, Byrnes KR, Faden AI: Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J Biol Chem 2009, 284(23):15629-15639. 22. Aramori I, Ferguson SS, Bieniasz PD, Zhang J, Cullen B, Cullen MG: Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 1997, 16(15):4606-4616. Page 13 of 14 23. Feniger-Barish R, Ran M, Zaslaver A, Ben-Baruch A: Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Cytokine 1999, 11(12):996-1009. 24. Clark MC, Baro DJ: Arthropod D2 receptors positively couple with cAMP through the Gi/o protein family. Comp Biochem Physiol B Biochem Mol Biol 2007, 146(1):9-19. 25. Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP: Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008, 85(3):335-353. 26. Shaw G, Morse S, Ararat M, Graham FL: Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 2002, 16(8):869-871. 27. Sohn SH, Chung HS, Ko E, Jeong HJ, Kim SH, Jeong JH, Kim Y, Shin M, Hong M, Bae H: The genome-wide expression profile of Nelumbinis semen on lipopolysaccharide-stimulated BV-2 microglial cells. Biol Pharm Bull 2009, 32(6):1012-1020. 28. Thomas DM, Francescutti-Verbeem DM, Kuhn DM: Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage. FASEB J 2006, 20(3):515-517. 29. Tooze J, Hollinshead M, Fuller SD, Tooze SA, Huttner WB: Morphological and biochemical evidence showing neuronal properties in AtT-20 cells and their growth cones. Eur J Cell Biol 1989, 49(2):259-273. 30. Sarret P, Nouel D, Dal Farra C, Vincent JP, Beaudet A, Mazella J: Receptor- mediated internalization is critical for the inhibition of the expression of growth hormone by somatostatin in the pituitary cell line AtT-20. J Biol Chem 1999, 274(27):19294-19300. 31. Winkler A, Papsdorf G, Odarjuk J, Siems WE, Fickel J, Melzig MF: Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells. Eur J Pharmacol 1995, 291(1):51-55. 32. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F: Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 1990, 27(2-3):229-237. 33. Franklin A, Stella N: Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol 2003, 474(2-3):195-198. 34. Vieira LB, Kushmerick C, Hildebrand ME, Garcia E, Stea A, Cordeiro MN, Richardson M, Gomez MV, Snutch TP: Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6. J Pharmacol Exp Ther 2005, 314(3):1370-1377. 35. Carlson RO, Masco D, Brooker G, Spiegel S: Endogenous ganglioside GM1 modulates L-type calcium channel activity in N18 neuroblastoma cells. J Neurosci 1994, 14(4):2272-2281. 36. Kirsch GE, Skattebol A, Possani LD, Brown AM: Modification of Na channel gating by an alpha scorpion toxin from Tityus serrulatus. J Gen Physiol 1989, 93(1):67-83. 37. Yang J: Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells. J Gen Physiol 1990, 96(6):1177-1198. 38. Alderton F, Sambi B, Tate R, Pyne NJ, Pyne S: Assessment of agonism at G- protein coupled receptors by phosphatidic acid and lysophosphatidic acid in human embryonic kidney 293 cells. Br J Pharmacol 2001, 134(1):6-9. 39. Cooper J, Hill SJ, Alexander SP: An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells. Br J Pharmacol 1997, 122(3):546-550. 40. Estacion M, Li S, Sinkins WG, Gosling M, Bahra P, Poll C, Westwick J, Schilling WP: Activation of human TRPC6 channels by receptor stimulation. J Biol Chem 2004, 279(21):22047-22056. 41. Mundell SJ, Matharu AL, Kelly E, Benovic JL: Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking. Biochemistry 2000, 39(42):12828-12836. 42. Mundell SJ, Loudon RP, Benovic JL: Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels. Biochemistry 1999, 38(27):8723-8732. 43. Schmidt M, Nehls C, Rumenapp U, Jakobs KH: m3 Muscarinic receptor- induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis. Mol Pharmacol 1996, 50(4):1038-1046. 44. Siehler S, Wang Y, Fan X, Windh RT, Manning DR: Sphingosine 1- phosphate activates nuclear factor-kappa B through Edg receptors.